Passionate about health and ethics issues, I had the chance with Pharmion and then Celgene to participate in the advent of immunotherapy by participating in the marketing in France of Imids from the beginning of the 2000s.
I wish to see the cure of an increasing number of cancers and I do this by promoting the Good Use of drugs with as much scientific rationale as possible, thus guaranteeing the best benefit/risk ratio for patients.
Pre-marketing of Thalidomide (IFM 99/06) in myelomas and 5-azacitidine (GFM AZA001) in myelodysplastic syndromes. 1/4th of France Territory East and South East.
Preparation of marketing authorizations and the launch of Thalidomide and Vidaza.
Hemostasis and coagulation: Responsible for the development of Refludan (Lepirudin) Anti-IIa Anti-Xa in HIT.
